{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:25:46Z","timestamp":1733876746749,"version":"3.30.1"},"reference-count":25,"publisher":"Medknow","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T00:00:00Z","timestamp":1463011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Current Ophthalmology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.joco.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T17:47:33Z","timestamp":1482860853000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy"],"prefix":"10.4103","volume":"29","author":[{"given":"Reza","family":"Zarei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Masoumpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasan","family":"Moghimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghasem","family":"Fakhraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadollah","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"key":"10.1016\/j.joco.2016.10.003_bib1","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajo.2011.08.005","article-title":"Subconjunctivalbevacizumab versus mitomycin C adjunctive to trabeculectomy","volume":"153","author":"Nilforushan","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib2","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.ophtha.2008.06.009","article-title":"Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study","volume":"115","author":"Grewal","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.joco.2016.10.003_bib3","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1167\/iovs.08-2662","article-title":"Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery","volume":"50","author":"Li","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.10.003_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.exer.2011.08.016","article-title":"The role of different VEGF isoforms in scar formation after glaucoma filtrationsurgery","volume":"93","author":"Van Bergen","year":"2011","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.joco.2016.10.003_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ICU.0b013e3283360aad","article-title":"Anti-VEGF therapy for glaucoma","volume":"21","author":"Horsley","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib6","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1167\/iovs.08-2441","article-title":"Postoperative use of bevacizumab as an antifibrotic agent in glaucoma filtration surgery in the rabbit","volume":"50","author":"Memarzadeh","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.10.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IJG.0b013e318287abf3","article-title":"Role of subconjunctival bevacizumab as an adjuvant to primary trabeculectomy: a prospective randomized comparative 1 Year follow up study","volume":"24","author":"Akkan","year":"2015","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.joco.2016.10.003_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jop.2012.0250","article-title":"The effect of bevacizumab on the outcome of trabeculectomy with 5-Fluorouracil","volume":"29","author":"Suh","year":"2013","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.joco.2016.10.003_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10792-012-9704-4","article-title":"Subconjunctival bevacizumab as an adjuvant in first-time filtration surgery for patients with primary glaucomas","volume":"33","author":"Biteli","year":"2013","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ajo.2010.03.025","article-title":"Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study","volume":"150","author":"Kahook","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib11","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/j.1442-9071.2011.02608.x","article-title":"Comparison of the use of 5-fluorouracil and bevacizumab in primary trabeculectomy: results at 1 year","volume":"40","author":"Jurkowska-Dudzi\u0144ska","year":"2012","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib12","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/IJG.0b013e31821826b2","article-title":"Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlledclinical trial","volume":"21","author":"Sengupta","year":"2012","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.joco.2016.10.003_bib13","first-page":"797","article-title":"Low-dose subconjunctivalbevacizumab to augment trabeculectomy for glaucoma","volume":"5","author":"Sedghipour","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib14","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/jop.2012.0035","article-title":"Comparison of needle revision with subconjunctival bevacizumab and 5-fluorouracil injection of failed trabeculectomy blebs","volume":"28","author":"Simsek","year":"2012","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"key":"10.1016\/j.joco.2016.10.003_bib15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin\u00ae) eye drops against corneal neovascularization","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/02713680903395273","article-title":"Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium","volume":"35","author":"Fallah","year":"2010","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.joco.2016.10.003_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1755-3768.2009.01795.x","article-title":"Topical bevacizumab is efficacious in the early bleb failure after trabeculectomy","volume":"89","author":"\u017barnowski","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib18","first-page":"66","article-title":"Topical bevacizumab as adjunctive therapy for bleb survival after trabeculectomy in the rabbit model","volume":"37","author":"Tripon","year":"2012","journal-title":"Philipp J Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12177-013-9108-3","article-title":"Post-trabeculectomy topical bevacizumab preventing bleb failure: a preliminary study","volume":"5","author":"Bhasker","year":"2012","journal-title":"J\u00a0Ocular Biol Dis Inf"},{"key":"10.1016\/j.joco.2016.10.003_bib20","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1755-3768.2009.01571.x","article-title":"The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization","volume":"88","author":"Habot-Wilner","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topicalbevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparativestudy","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.joco.2016.10.003_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0079-6123(08)01117-5","article-title":"Modulation of wound healing during and after glaucoma surgery","volume":"173","author":"Georgoulas","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.joco.2016.10.003_bib23","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.joco.2016.10.003_bib24","first-page":"18","article-title":"Delayed corneal epithelial healing after intravitreal bevacizumab: a clinical and experimental study","volume":"6","author":"Colombres","year":"2011","journal-title":"J\u00a0Ophthalmic Vis Res"},{"key":"10.1016\/j.joco.2016.10.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/15428877-20100215-07","article-title":"Corneal melt while using topical bevacizumab eye drops","volume":"9","author":"Galor","year":"2010","journal-title":"Ophthalmic Surg Lasers Imaging"}],"container-title":["Journal of Current Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452232516300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452232516300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T13:19:01Z","timestamp":1692623941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452232516300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2452232516300683"],"URL":"https:\/\/doi.org\/10.1016\/j.joco.2016.10.003","relation":{},"ISSN":["2452-2325"],"issn-type":[{"type":"print","value":"2452-2325"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy","name":"articletitle","label":"Article Title"},{"value":"Journal of Current Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joco.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016, Iranian Society of Ophthalmology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}